© 2018 LabShares Newton LLC

fog.png

FogPharma

FogPharma was born from the scientific and entrepreneurial vision of founder Greg Verdine, a pioneer in the discovery and development of new drug classes that “drug the undruggable.”

 

FogPharma’s cell-penetrating miniproteins (CPMPs) are a broad new class of medicines that can drug targets beyond the reach of conventional therapeutics.

 

Together with world-leading experts and collaborators in cancer biology and therapy, their team is building a drug discovery powerhouse having passion, knowledge, and creativity to develop fundamentally new cancer treatments.